Zobrazeno 1 - 10
of 30
pro vyhledávání: '"N N, Bagmet"'
Publikováno v:
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, Vol 20, Iss 1, Pp 30-37 (2024)
Aim of the review. To present up-to-date management approach to biliary cysts of the liver and polycystosis.Original positions. Opinions of surgeons differ in the issue of whom and when to operate, as well as in the choice of intervention procedure.
Externí odkaz:
https://doaj.org/article/e3641f4fa0df4eea893a4ccb7a4e19d8
Publikováno v:
Современная онкология, Vol 22, Iss 3, Pp 109-113 (2020)
Over the past two decades, many new variants of targeted therapy for metastatic colorectal cancer (mCRC) had appeared, and significantly increased patient survival. However, there were questions relating to the definition of the optimal sequence and
Externí odkaz:
https://doaj.org/article/5e4f261f79964feabb01d7d3d9dc1d9c
Autor:
M I Sekacheva, N N Bagmet
Publikováno v:
Современная онкология, Vol 18, Iss 3, Pp 43-47 (2016)
The problem of the treatment of metastatic colorectal cancer makes us to continue for seeking new ways of severe disease treatment. Regorafenib is the newest drug for use in patients who have received all possible variants of therapy. The efficacy an
Externí odkaz:
https://doaj.org/article/aa2af41e1ce24598bbc355618fa9908c
Autor:
Yu. V. Kulezneva, L. I. Kurmanseitova, I. V. Patrushev, M. G. Efanov, V. V. Tsvirkun, O. V. Melekhina, S. G. Shapovalyants, E. D. Fedorov, S. A. Budzinsky, V. V. Shcheglov, R. F. Belyakov, A. N. Petrovsky, A. Yu. Popov, A. B. Sidorenko, N. N. Bagmet, S. A. Trifonov, A. A. Sutyagin, Sh. Sh. Gadaev, M. N. Konysov, K. N. Khisteva, A. A. Chitadze, A. B. Musatov
Publikováno v:
Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery. 26:105-113
Aim. To demonstrate the first results of the work on database created to assess long-term results of treatment of patients with posttraumatic biliary strictures and to develop a unified approach to the management of these patients.Materials and metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4fb87b952be5755182bde1b0cbb07f54
https://doi.org/10.16931/1995-5464.2021-4-105-113
https://doi.org/10.16931/1995-5464.2021-4-105-113
Autor:
O G Skipenko, D A Chekunov, G A Shatverian, N N Bagmet, M I Sekacheva, R S Polyakov, A L Bedzhanyan, A G Abdullaev, Ya G Moysyuk
Publikováno v:
Современная онкология, Vol 17, Iss 3, Pp 61-69 (2015)
Background. Hepatocellular carcinoma (HCC) is a malignancy of the liver associated with poor prognosis. The understanding of the prevalence of liver damage and functional status of the liver can complicate therapy in these patients and often requires
Externí odkaz:
https://doaj.org/article/24f0e2cea78d418aa0b7accb804a5108
Autor:
M. I. Sekacheva, E. M. Paltseva, N. N. Bagmet, A. L. Bedzhanyan, L. O. Polishchuk, O. G. Skipenko
Publikováno v:
Тазовая хирургия и онкология, Vol 0, Iss 3, Pp 11-17 (2015)
Panitumumab has been shown to increase progression free and overall survival in patients with metastatic colorectal cancer.Our purpose was to evaluate whether panitumumab is effective and safe in patients with potentially resectable colorectal liver
Externí odkaz:
https://doaj.org/article/d3c1c7825e934fd78a5c6eb2c63a8fb1
Publikováno v:
Современная онкология, Vol 15, Iss 2, Pp 26-30 (2013)
Whether it is expedient and safe to add bevacizumab to preoperative treatment regimens for colorectal cancer liver metastases has been remained unclear over many years in spite of the duration of its use in this category of patients. In our trial, in
Externí odkaz:
https://doaj.org/article/9c4be52370d241929a0fe903735fca1c
Publikováno v:
Современная онкология, Vol 15, Iss 2, Pp 22-25 (2013)
To treat colorectal cancer liver metastases presents still a challenge and to take tactical decisions requires the participation of a multidisciplinary team of specialists. Despite significant progress in the drug therapy of this disease, the best lo
Externí odkaz:
https://doaj.org/article/2ce43b0c2588413c9aa9ae83680d025c
Publikováno v:
Современная онкология, Vol 22, Iss 3, Pp 109-113 (2020)
Over the past two decades, many new variants of targeted therapy for metastatic colorectal cancer (mCRC) had appeared, and significantly increased patient survival. However, there were questions relating to the definition of the optimal sequence and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::999dc22214412ef50445453fc989dff8
https://doi.org/10.26442/18151434.2020.3.200342
https://doi.org/10.26442/18151434.2020.3.200342
Publikováno v:
Современная онкология, Vol 14, Iss 2, Pp 38-41 (2012)
Externí odkaz:
https://doaj.org/article/d741eebd99904b7eb38c76fa1bc603cc